Literature DB >> 22636604

Further delineation of the phenotype of chromosome 14q13 deletions: (positional) involvement of FOXG1 appears the main determinant of phenotype severity, with no evidence for a holoprosencephaly locus.

Gijs W E Santen1, Yu Sun, Antoinet C J Gijsbers, Aurore Carré, Maureen Holvoet, Arie van Haeringen, Saskia A J Lesnik Oberstein, Akemi Tomoda, Hiroyo Mabe, Michel Polak, Koenraad Devriendt, Claudia A L Ruivenkamp, Emilia K Bijlsma.   

Abstract

BACKGROUND: Deletions including chromosome 14 band q13 have been linked to variable phenotypes. With current molecular methods the authors aim to elucidate a genotype-phenotype correlation by accurately determining the size and location of the deletions and the associated phenotype.
METHODS: Here the authors report the molecular karyotyping and phenotypic description of seven patients with overlapping deletions including chromosome 14q13.
RESULTS: The authors show that deletions including 14q13 result in a recognisable phenotype mainly due to haploinsufficiency of two genes (NKX2-1, PAX9). FOXG1 (on chromosome band 14q12) involvement seems to be the main determinant of phenotype severity. The patients in this study without FOXG1 involvement and deletions of up to 10 Mb have a relatively mild phenotype. The authors cannot explain why some patients in literature with overlapping but smaller deletions appear to have a more severe phenotype. A previously presumed association with holoprosencephaly could not be confirmed as none of the patients in this series had holoprosencephaly.
CONCLUSIONS: FOXG1 appears the main determinant of the severity of phenotypes resulting from deletions including 14q13. The collected data show no evidence for a locus for holoprosencephaly in the 14q13 region, but a locus for agenesis of the corpus callosum cannot be excluded.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22636604     DOI: 10.1136/jmedgenet-2011-100721

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  12 in total

1.  Six3 dosage mediates the pathogenesis of holoprosencephaly.

Authors:  Xin Geng; Sandra Acosta; Oleg Lagutin; Hyea Jin Gil; Guillermo Oliver
Journal:  Development       Date:  2016-10-21       Impact factor: 6.868

2.  Comprehensive genotyping and clinical characterisation reveal 27 novel NKX2-1 mutations and expand the phenotypic spectrum.

Authors:  Anne Thorwarth; Sarah Schnittert-Hübener; Pamela Schrumpf; Ines Müller; Sabine Jyrch; Christof Dame; Heike Biebermann; Gunnar Kleinau; Juri Katchanov; Markus Schuelke; Grit Ebert; Anne Steininger; Carsten Bönnemann; Knut Brockmann; Hans-Jürgen Christen; Patricia Crock; Francis deZegher; Matthias Griese; Jacqueline Hewitt; Sten Ivarsson; Christoph Hübner; Klaus Kapelari; Barbara Plecko; Dietz Rating; Iva Stoeva; Hans-Hilger Ropers; Annette Grüters; Reinhard Ullmann; Heiko Krude
Journal:  J Med Genet       Date:  2014-04-08       Impact factor: 6.318

3.  Identical deletion at 14q13.3 including PAX9 and NKX2-1 in siblings from mosaicism of unaffected parent.

Authors:  Shin Hayashi; Mariko Yagi; Ichijiro Morisaki; Johji Inazawa
Journal:  J Hum Genet       Date:  2015-01-22       Impact factor: 3.172

4.  Identification of multiple DNA copy number alterations including frequent 8p11.22 amplification in conjunctival squamous cell carcinoma.

Authors:  Laura Asnaghi; Hind Alkatan; Alka Mahale; Maha Othman; Saeed Alwadani; Hailah Al-Hussain; Sabah Jastaneiah; Wayne Yu; Azza Maktabi; Deepak P Edward; Charles G Eberhart
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-12-09       Impact factor: 4.799

5.  Platelet defects in congenital variant of Rett syndrome patients with FOXG1 mutations or reduced expression due to a position effect at 14q12.

Authors:  Christophe Goubau; Koen Devriendt; Nathalie Van der Aa; An Crepel; Dagmar Wieczorek; Tjitske Kleefstra; Marjolein H Willemsen; Anita Rauch; Andreas Tzschach; Thomy de Ravel; Peter Leemans; Chris Van Geet; Gunnar Buyse; Kathleen Freson
Journal:  Eur J Hum Genet       Date:  2013-05-01       Impact factor: 4.246

6.  FOXG1 syndrome: genotype-phenotype association in 83 patients with FOXG1 variants.

Authors:  Diana Mitter; Milka Pringsheim; Marc Kaulisch; Kim Sarah Plümacher; Simone Schröder; Rita Warthemann; Rami Abou Jamra; Martina Baethmann; Thomas Bast; Hans-Martin Büttel; Julie S Cohen; Elizabeth Conover; Carolina Courage; Angelika Eger; Ali Fatemi; Theresa A Grebe; Natalie S Hauser; Wolfram Heinritz; Katherine L Helbig; Marion Heruth; Dagmar Huhle; Karen Höft; Stephanie Karch; Gerhard Kluger; G Christoph Korenke; Johannes R Lemke; Richard E Lutz; Steffi Patzer; Isabelle Prehl; Konstanze Hoertnagel; Keri Ramsey; Tina Rating; Angelika Rieß; Luis Rohena; Mareike Schimmel; Rachel Westman; Frank-Martin Zech; Barbara Zoll; Dörthe Malzahn; Birgit Zirn; Knut Brockmann
Journal:  Genet Med       Date:  2017-06-29       Impact factor: 8.822

7.  Parallel Tests of Whole Exome Sequencing and Copy Number Variant Sequencing Increase the Diagnosis Yields of Rare Pediatric Disorders.

Authors:  Xuyun Hu; Ruolan Guo; Jun Guo; Zhan Qi; Wei Li; Chanjuan Hao
Journal:  Front Genet       Date:  2020-06-11       Impact factor: 4.599

8.  Pax9 is required for cardiovascular development and interacts with Tbx1 in the pharyngeal endoderm to control 4th pharyngeal arch artery morphogenesis.

Authors:  Helen M Phillips; Catherine A Stothard; Wasay M Shaikh Qureshi; Anastasia I Kousa; J Alberto Briones-Leon; Ramada R Khasawneh; Chloe O'Loughlin; Rachel Sanders; Silvia Mazzotta; Rebecca Dodds; Kerstin Seidel; Timothy Bates; Mitsushiro Nakatomi; Simon J Cockell; Jürgen E Schneider; Timothy J Mohun; René Maehr; Ralf Kist; Heiko Peters; Simon D Bamforth
Journal:  Development       Date:  2019-09-23       Impact factor: 6.868

Review 9.  14q12q13.2 microdeletion syndrome: Clinical characterization of a new patient, review of the literature, and further evidence of a candidate region for CNS anomalies.

Authors:  Emanuela Ponzi; Mattia Gentile; Emanuele Agolini; Emilia Matera; Roberto Palumbi; Antonia Lucia Buonadonna; Antonia Peschechera; Alessandra Gabellone; Maria Fatima Antonucci; Lucia Margari
Journal:  Mol Genet Genomic Med       Date:  2020-05-16       Impact factor: 2.183

10.  A novel 14q13.1-21.1 deletion identified by CNV-Seq in a patient with brain-lung-thyroid syndrome, tooth agenesis and immunodeficiency.

Authors:  Xuyun Hu; Jun Liu; Ruolan Guo; Jun Guo; Zhipeng Zhao; Wei Li; Baoping Xu; Chanjuan Hao
Journal:  Mol Cytogenet       Date:  2019-12-19       Impact factor: 2.009

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.